AtriCure to Announce Third Quarter 2023 Financial Results

Rhea-AI Summary

AtriCure, Inc. to release Q3 2023 financial results on November 1, 2023

Positive

• AtriCure will release its Q3 2023 financial results on November 1, 2023.

Negative

• None.

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its third quarter 2023 financial results on Wednesday, November 1, 2023.

AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Wednesday, November 1, 2023, to discuss its third quarter 2023 financial results. Those interested in listening to the conference call should register online using this link. Participants are encouraged to register more than 15 minutes before the start of the call. A live and replay version of the audio webcast will be available at https://ir.atricure.com/events-and-presentations/events.

About AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231011128214/en/

Angie Wirick

AtriCure, Inc.

Chief Financial Officer

(513) 755-5334

awirick@atricure.com



Lynn Lewis or Marissa Bych

Gilmartin Group

Investor Relations

lynn@gilmartinir.com

marissa@gilmartinir.com

Source: AtriCure, Inc.

FAQ

When will AtriCure release its Q3 2023 financial results?

AtriCure will release its Q3 2023 financial results on November 1, 2023.

What time will the audio webcast take place?

The audio webcast will take place at 4:30 p.m. Eastern Time on November 1, 2023.

Where can I listen to the conference call?

You can listen to the conference call by registering online using the provided link.

Will there be a replay of the audio webcast?

Yes, a replay version of the audio webcast will be available at the provided link.